Visby Medical
Visby Medical58
Visby Medical
Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.
About
What does Visby Medical do?
Visby Medical is a diagnostics company focused on transforming the detection and treatment of infectious diseases. They develop and manufacture a portable, instrument-free, single-use PCR device that delivers accurate, lab-quality results in under 30 minutes directly at the point of care, enabling rapid diagnosis and treatment decisions. (formerly Click Diagnostics.)
What is Visby Medical's revenue?
StartupHub estimates Visby Medical's annual revenue at $35.3M (range $30.4M to $61.8M, 66% confidence), based on comparable companies in the sector.
What is Visby Medical's valuation?
StartupHub estimates Visby Medical's effective valuation at $612.4M (range $428.7M to $796.1M, 27% confidence), based on comparable companies in the sector.
How much funding has Visby Medical raised?
Visby Medical has raised a total of $331M in funding. The most recent round on record is Series E.
Where is Visby Medical headquartered?
Visby Medical is headquartered in San Jose, United States.
When was Visby Medical founded?
Visby Medical was founded in 2012.
What industry does Visby Medical operate in?
Visby Medical operates in Healthcare, MedTech, HealthTech, Diagnostics, Infectious Disease Diagnostics, Point-of-Care Testing.
How many employees does Visby Medical have?
Visby Medical has approximately 179 people on record.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Longevity and metabolic health platform offering personalized insights and interventions.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“The Visby Medical Women’s Sexual Health Test is a prescription-free test that has received approval from the FDA for an innovative at-home diagnostic solution. This test detects chlamydia, gonorrhea, and trichomoniasis and delivers results…”
View on Reddit“The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…”
View on Reddit“The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…”
View on Reddit“The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…”
View on Reddit“The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…”
View on Reddit“The Visby Medical Women's Sexual Health Test is a single-use test intended for women with or without symptoms. The FDA granted marketing authorization to Visby Medical based on testing that showed the device correctly identified 98.8% of ne…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.